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INTRODUCTION 
 The human herpes virus is an important source of ophthalmic 
morbidity worldwide.  Herpes simplex virus however, continues to be 
an important cause of unilateral corneal blindness worldwide. It is a 
multifaceted disease capable of inducing the most baffling problems 
through both infectious and immune mechanisms. Despite considerable 
progress in understanding the virus at cellular and molecular levels the 
prospect of prevention still appears to be a long way off. 
 
VIROLOGY  
 Herpes simplex virus belongs to a family of viruses called 
Herpesviridae. They are composed of a central deoxyribo nueclic acid    
Core and a protein capsid with 162 hollow cylindrical capsomeres. This 
nucleocapsid is surrounded by an envelope forming a virus particle 
(virion) with an overall diameter of 130-180nm.  
 
VIRUS TYPES:  
 There are two types of herpes simplex virus , namely, type 1 and 
2. In general, type 1 causes infection above the waist like herpes labialis 
  
and dermatitis and type2, below the waist (Herpes genitalis).  Thus the 
rare neonatal herpes simplex virus infection including herpetic keratitis 
and conjunctivitis is due to herpes simplex virus  type 2 in a majority of 
cases.  
 
VIRAL STRAINS:  
 The severity and frequency of ocular disease may be influenced 
by strain difference. Strains which produce large amount of 
glycoproteins are capable of inducing more humoral and cell-mediated 
immune response16. These strains may be associated with more severe 
form of corneal stromal disease. The viral genome may also play a role 
in determining the clinical response to topical steroids.  
 
 
 
 
 
 
  
PATHOGENESIS 
It causes a lytic infection17 Herpes simplex virus usually affects 
tissues of ectodermal origin, such as skin, mucous membrane, or the 
nervous system. After the attachment to specific receptors on the surface 
of human cell membrane it enters the cells by pinocytosis (penetration). 
The deoxyribo nueclic acid released into the cells travels to the nucleus. 
There follows an eclipse period during which no virus can be detected. 
In fact the viral deoxyribo nueclic acid    induces the production of both 
host and virus-specific enzymes, namely, thymidine kinase and 
deoxyribo nueclic acid polymerase. Viral proteins synthesised in the 
cytoplasm are transferred to the nucleus where the nucleocapsid is 
assembled. The nucleocapsid gains an envelope as they bud through the 
nuclear membrane. The host cell become packed with such particles 
before it ultimately undergoes cell lysis and releases the infectious 
particles.  
LATENCY AND REACTIVATION 
 Like other herpes viruses herpes simplex virus has the ability to 
induce latent infection. After primary infection, that is the host’s first 
exposure at the peripheral site, the virus enters the sensory nerve 
  
endings which supply the site of peripheral epithelial infection, usually 
the oropharynx. Virus particles travel centripetally to the neuronal cell 
body by retrograde axoplasmic flow. Here they can survive for decades 
probably integrated into the host-cell nuclear deoxyribo nueclic acid yet 
they leave the cell morphologically, antigenically, and functionally 
normal. 
 
The virus enters the trigeminal ganglion via any of the 3 major 
divisions of the fifth nerve. The reactivated virus may travel down by 
centrifugal axoplasmic flow despite and independent of the original 
portal of entry to cause peripheral disease.  
  
The cornea itself is a site of persistent infection12; therefore 
injudicious use of topical steroids in chronic disease may promote 
proliferation and penetration of virus within the cornea. For the same 
reason considerable care must be taken while selecting patients with 
corneal opacification for treatment with phototherapeutic keratectomy.  
 
 
  
CLINICAL FEATURES 
PRIMARY INFECTION  
Neonates are protected by maternal antibody for six months. 
Infection with herpes simplex virus  for the first time can develop at any 
age although most cases occur within the first few years of life. Salivary 
contamination from a person with silent salivary shedding of herpes 
labialis is the most common source of infection. Aphthous  stomatitis is 
the usual clinical picture, which can range from subclinical to very 
severe infection. However primary herpes simplex virus infection can 
also occur in other mucous membranes, including the conjunctiva.  
 
PRIMARY OCULAR HERPES SIMPLEX VIRUS  INFECTION 
It most commonly manifests as blepharoconjunctivitis which is 
predominantly unilateral. The periorbital skin can develop intense 
blisters associated with conjunctivitis and blepharitis. Extensive spread 
on the facial skin can occur, particularly in eczematous individuals. 
Herpetic canaliculitis can lead to punctal stenosis. 
  
  
The conjunctivitis is usually follicular although severe cases may 
develop pseudo-membranous reaction. Preauricular lymphadenopathy 
often accompanies the conjuctival involvement in 30-50% of cases. Some 
times it is difficult to distinguish acute follicular conjunctivitis caused by 
herpes simplex virus from that caused by adenovirus. Signs that can be 
used to distinguish herpes simplex virus keratitis from adenovirus 
keratitis include the following 
• The distinctive dendritic morphology of herpes simplex virus  
keratitis 
• The presence in primary herpes simplex virus of cutaneous 
vesicles 
• The lack of an associated epidemic 
• Unilaterality (only 10% of herpes simplex virus keratitis cases are 
bilateral, whereas the majority of adenovirus keratoconjunctivitis 
cases have bilateral involvement) 
 
The morphology of the corneal lesions varies from superficial 
punctate keratitis, microdendrites or frank dendritic ulceration. Stromal 
  
involvement and uveitis is rare occurring in <10% of patients with 
primary ocular herpes simplex virus.  
 
Diagnosis:  
 In cases in which a clinical diagnosis cannot be made, laboratory 
tests (culture or antigen detection) may be helpful. Serological testing is 
generally of limited value in establishing a diagnosis because over 90% 
of the adult population shows serological evidence of herpes simplex 
virus -1 infection. Therefore, a single positive lgG titer is nondiagnostic, 
whereas a negative result may be helpful in excluding herpes simplex 
virus -related disease (on a retrospective basis). A minimum fourfold 
rise in antibody titer and /or the presence of IgM class antibodies may 
be helpful in making a retrospective diagnosis of primary infection. 
RECURRENT INFECTION:  
The major factors which dictate the severity of recurrent herpes are;  
• Genetic constituent of host 
•  Immune response of the host 
• The viral strain 
• Treatment 
  
Superficial corneal lesions (dendritic and geographic ulcers) are 
associated with the presence of replicating virus while deeper lesions 
(stromal, uveal) appear to be predominantly due to the immune 
response.  
 
BLEPHAROCONJUNCTIVITIS:  
Eyelid and /or conjunctival involvement may occur in patients 
with recurrent ocular herpes simplex virus infection. Blepharo 
conjunctivitis may or may not accompany epithelial keratitis. 
 
CORNEAL EIPTHELIAL DISEASE:  
The morphology of the lesions are quite varied. They can appear as  
• superficial punctate keratitis  
• stellate epithelial lesions  
• Dendritic ulcer 
•  geographic ulcers. 
 
 The vast majority of cases of herpes simplex virus keratitis are 
those, which present with a corneal epithelial lesion, usually a dendritic 
  
ulcer. Such individuals may experience first episode in adulthood. This 
is due to reactivation of a latent virus from a previously unrecognized 
primary ocular infection or from a virus, which has reached the 
ophthalmic neurons in the trigeminal ganglion during primary infection 
of the oropharynx. It usually occurs as isolated lesion(s) without 
involvement of conjunctiva and lids. The presenting symptoms include 
irritation, watering, photophobia, and occasionally, blurring of vision. 
Cold sores are common in such individuals but are rarely simultaneous.  
 
Ulcers are usually single but may be several. The lesion begins 
discrete punctate epithelial keratitis, and then coalesce into dendritic 
shape lesion consisting of swollen opaque epithelial cells. The 
mechanism for dendrite formation is not known, but is thought to be 
related to linear spread of virus from cell to cell in a contiguous manner. 
With further growth of the dendrite the central epithelium is sloughed 
off and the lesion stains with fluorescein. The marginal infected cells 
take up rose bengal stain. The linear branches characteristically end in 
expansions called “terminal bulbs”. The stroma under the ulcer may 
show a faint haze and there may be evidence of subepithelial infiltrates, 
  
which mirror the shape of corneal dendrites and are termed “ghost 
dendrites”. They serve as marker for recent epithelial keratitis. Corneal 
sensation is lost in the areas where lesions are present. Repeated attacks 
may result in generalized corneal anaesthesia. The distribution of 
corneal hypoesthesia is related to extent, duration, severity and is 
difficult to detect. It is not a reliable sign of herpetic disease. 
 
Geographic ulcer develops as a result of centrifugal spread of 
herpes simplex virus towards peripheral cornea. Risk factors for its 
development include strain of infecting virus, topical or systemic 
immuno suppressive therapy and HIV infection. 
Typical lesions involve the central cornea. Ulcers at the periphery 
of the cornea may behave differently sometimes masquerading as 
ulceration due to staphylococcal infection. They appear to be more 
resistant to treatment and to have more stromal complications26. They 
are also predisposed to chronic tropic ulceration. In a majority of 
patients healing occurs with minimal stromal scarring. Repeated attacks 
and severe infections may result in stromal scarring thinning and 
vascularization.  
  
STROMAL KERATITIS:  
 Stromal disease may be divided into infection and immune 
categories according to currently indicated pathogenesis: 
• Infectious disease characterized by necrotizing stromal keratitis; 
• Antigen antibody-complement-mediated immune disease 
characterised by viral interstitial keratitis, immune rings or limbal 
vasculitis; 
• Delayed hypersensitivity reaction characterized by disciform 
edema.  
 
Necrotising stromal keratitis is typically associated with 
ulceration. It can follow epithelial disease, superficial stromal disease or 
disciform keratitis, and is believed to be due to active viral replication 
and intense immune stromal inflammation. It may be generalized or 
localized. These cases may have to be differentiated from other forms of 
microbial keratitis and indeed secondary infection with bacteria and 
fungal can complicate herpes simplex virus  stromal keratitis. Secondary 
complications include hypopyon, uveitis, posterior synechiae, 
glaucoma, retrocorneal membrane, cataract, and rarely, perforation. 
  
All three forms of herpetic antigen antibody complex-mediated 
disease are thought to be due to immune complex hypersensitivity. The 
interstitial keratitis presents clinically as single or multiple patches of 
dense white necrotic infiltrates. After several weeks of smoldering, 
deep, dense leashes of vessels often move in.  
 
Immune-mediated stromal keratitis is the most common form of 
the stromal disease where an antibody response is mounted against the 
viral antigen present in the stroma expressed as a result of persistent 
infection. There is deposition of antigen-antibody-complement in the 
stroma. Animal studies show additional mechanisms involved in the 
stromal tissue destruction. It is proposed that CD4+T cells play a 
significant role in the recognition of antigens presented by Langerhan’s 
cells, which migrate from limbus to central cornea after herpes simplex 
virus  type 1 infection. The activated CD4+T cells release cytokines, in 
particular interleukin 2 and gamma interferon. Both factors attract large 
numbers of polymorphonuclear leucocytes, which are responsible for 
corneal tissue destruction.  
  
  
Another distinct form of stromal infiltrate is the immune ring of 
wessely. This represents a circular deposit of antigen-antibody 
complexes with polymorphonuclear leucocyte infiltrate as a result of 
complement activation.  
  
Traditionally disciform keratitis has been described under stromal 
keratitis. However the recent trend is to describe it under endothelitis as 
the actual mechanism involved is thought to be endothelial cell infection 
by herpes simplex virus and associated inflammation.  
 
INDOLENT ULCERATION:  
 Development of persistent epithelial defects or recurrent 
epithelial erosions can be seen with herpes simplex virus epithelial 
infection. These are generally round or ovoid ulcers with a grey and 
thickened margin, which is due to piled up epithelial cells. 
The mechanism appears to be due to damage to underlying 
basement membrane at the time of epithelial infection and denervation. 
Consequently the epithelium fails to adhere to the basement membrane 
resulting in persistent defect or recurrent erosion. Additional factors like 
  
lack of trophic innervations, drug toxicity and stromal inflammation 
may play a role. Viral cultures are negative and the base of the ulcer 
stains with both rose bengal and fluorescein. Persistent ulcers have the 
potential to progress to corneal melt, perforation and superinfection.  
 
 Indolent ulcers (sometimes referred to as “metaherpetic”) have to 
be differentiated from geographic ulcers, which are characteristically 
caused by inappropriate steroid use. The latter have flat edges and stain 
with rose bengal stain. They also change shape due to continued viral 
progression. Viral cultures will be positive.  
 
HERPES SIMPLEX VIRUS  ENDOTHELIITIS:  
 Progressive or nonprogressive forms of endothelial inflammation 
can occur with type 1 herpes simplex virus infection. Dendritic 
ulceration can precede these lesions in some patients. Disciform keratitis 
is the most common form in which a disc-shaped area of stromal edema 
occurs without infiltration or vascularization. The area of involvement 
may be diffuse and central or eccentric. The presenting symptoms 
include watering, photophobia, discomfort or blurred vision. A history 
  
of herpetic eye disease is usually present. The involved cornea shows 
appreciable thickening of all layers sometimes with epithelial edema 
and often with folds in Descements membrane. Careful examination 
usually reveals keratic precipitates (Kps) in the affected area associated 
with mild anterior chamber activity. Spontaneous clearing can follow 
although progression to necrotizing keratitis, vascularization, scarring 
and thinning is also possible. Delayed hypersensitivity mediated by T 
lymphocytes is probably important in the pathogenesis of disciform 
keratitis. The distribution of KPs strictly confined to the endothelium 
behind the swollen area suggests cell-mediated reaction directed at 
herpes simplex virus determinants on the surface of endothelial cells43.  
 
 Rarely linear involvement of the endothelium can occur. In these 
cases stromal edema is seen associated with KPs separating the involved 
and uninvolved cornea similar to the Khodhadoust line of corneal graft 
rejection. Slitlamp examination may show dark areas in the endothelium 
which appear as nonreflective black endothelial areas under a specular 
microscope. There may be progression of the endothelial line and the 
associated stromal edema. Immunological studies on the aqueous 
  
aspirates have revealed herpes simplex virus antigen in several of these 
cases.  
 
HERPES SIMPLEX VIRUS  IRIDOCYCLITIS:  
 All deeper forms of herpes simplex keratitis can be associated 
with uveitis. However recurrent nongranulomatous anterior uveitis 
may be an isolated manifestation of herpes simplex virus ocular 
involvement. Immunological reaction was thought to be the cause in 
most of the cases although in some cases live viruses have been 
demonstrated in the anterior chamber and iris tissue33.  
 
 Clinically the severity can vary from mild to severe inflammation 
which may result in fibrin formation, hypopyon, hyphema, posterior 
synechiae, segmental iris necrosis similar to the picture seen in zoster 
keratouveitis, and inflammatory membrane in the angle of the anterior 
chamber with secondary glaucoma.  
 
 
 
  
TRABECULITIS: 
 Herpetic peripheral corneal involvement may extend to the 
trabecular meshwork resulting in trabeculitis. The resultant secondary 
glaucoma may be transient or lead to permanent damage.  
 
AIDS AND HERPES SIMPLEX KERATITIS :  
 The experience of herpes simplex keratitis in post-transplant 
immuno suppressed patients suggests that the condition may be more 
common and more serious than in immuno competent individuals.  It is 
not as typical as in immuno competent patients. In HIV patients there is 
a predilection for peripheral as opposed to corneal involvement. More 
frequent recurrence and prolonged clinical course requiring 2-4weeks of 
antiviral therapy. If it is assumed that after a first episode a site of 
chronic latent infection is established in the cornea this suggests, the 
immuno suppression by HIV infection may impair those mechanisms 
which are normally responsible for containing such an infection in the 
cornea42. 
 
 
  
COMPLICATIONS OF HERPETIC EYE DISEASE 
Epithelial complications:  
• Diffuse punctate or vortex epitheliopathy due to topical antiviral 
toxicity. 
• Recurrent epithelial erosions due to trauma to the basement 
membrane 
• Non healing trophic epithelial defects due to corneal anesthesia 
may develop which will lead on to trophic ulcers. 
• Corneal stromal thinning and perforation rarely due to 
nonhealing trophic epithelial defects. 
 
Stromal Complications: 
• Corneal Stromal scarring leading to surface irregularity  
• Irregular astigmatism which may be corrected by carefully fitted 
gas-permeable hard contact lens, but this might induce recurrence 
of herpetic keratitis  
• Stromal opacification may diminish gradually  
• Lipid Keratopathy in patients with corneal stromal 
vascularization.  
  
TRIGGER FACTORS FOR REACTIVATION10 
 Deficient immune competence 
 Intracellular messenger system 
 Physical or emotional stress 
 Immuno compromised state 
 Fever 
 Cold wind 
 Systemic illness 
 Surgery 
 Menstruation 
 Trigeminal root ganglion section 
 Immuno suppression 
 Local trauma, laser glaucoma surgery, refractive surgery 
 
 
 
 
 
 
  
LABORATORY DIAGONSIS 
 Laboratory tests are not an absolute requisite for the diagnosis of 
herpes simplex virus infection as clinical features are often highly 
characteristic (central location, rose Bengal staining pattern and terminal 
bulbs).  However, we believe whenever possible culture should be 
undertaken to establish a firm diagnosis. The chronic nature of the 
condition is such that a positive diagnosis once established, is invaluable 
in guiding management over what may be many years.  
 
 The available methods include virus culture, immunological tests, 
and histopathological examination of keratoplasty specimens.  
 
 Tzanck technique, staining of epithelial scrapings taken from the 
skin or corneal ulcers. Microscopic examination of the Giemsa-stained 
smear may, but does not invariably reveal typical eosinophilic viral 
inclusion bodies of Lipschutz in the nuclei. Other stains used are 
Wrights, hematoxylin-eosin, Papanicolauou’s methylene blue and 
Paragon multiple. The epithelial cells themselves show ballooning 
  
degeneration and a monocytic white cell infiltrate characteristic of viral 
infection is always present.  
 
The definitive methods of diagnostic testing is isolating virus in 
tissue culture. The lesion is swabbed and placed in viral transport 
medium and sent to the laboratory. It is then inoculated on to cell 
monolayers and incubated at 37°c. A typical cytopathic effect is 
generally noticed in 2-4 days.  
 
Additional more sophisticated, sensitive and selective tests 
require more complicated technology and equipment. These tests are 
worthwhile however in cases where the diagnosis remain in doubt. 
They include immuno morphological evaluation of scrapings from 
vesicles, for example immuno fluorescent electron microscopy, immuno 
peroxidase staining, radioimmunoassay, agar gel immuno diffusion and 
deoxyribo nueclic acid probes. Serological evaluation tests include 
fluorescent antibody staining of membrane antigen, immune adherence 
hemagglutination assay, enzyme –linked immunosorbent assay (ELISA),  
complement fixation, and neutralization tests. Of the above, the most 
  
readily available and extremely sensitive test is the commercially 
marketed HERPCHEK which is based on the ELISA system.  
 
Histopathological examination of keratectomy specimens may 
show granulomatous reaction in deep stroma and around Descemet’s 
membrane. Immunocytochemistry may demonstrate herpes simplex 
virus antigens in stromal keratocytes, endothelial cells and epitheloid 
cells. These are more often seen with the necrotising type of herpetic 
stromal keratitis.                 
 
 
 
 
 
 
 
 
 
  
MEDICAL MANAGEMENT 
ANTIVIRAL AGENTS  
 The following topical agents are currently available for use in 
herpes simplex keratitis. Idoxyuridine, a thymidine analogue was the 
first agent found to be effective in the treatment of herpes simplex virus 
keratitis. It is incorporated into the viral deoxyribo nueclic acid, 
produces faulty deoxyribo nueclic acid chain and also inhibits viral 
enzyme. It also incorporates into normal host cells which accounts for its 
toxicity9. Available as Iodoxyuridine 0.01% drops Q2 hours. Though 
idoxyuridine is useful in treating epithelial infection the problems of 
toxicity, allergic reaction, clinical viral resistance, poor solubility and 
penetration, and rapid inactivation have led to the use of other antiviral 
drugs. Notable ocular side effects include contact dermatitis, punctate 
keratitis, epithelial opacification, chronic epithelial defects, lacrimal 
punctal stenosis, follicular conjunctivitis, corneal pannus and 
teratogenicity in rabbits.  
 
 Vidarabine, the second agent developed for human use, inhibits 
viral deoxyribo nueclic acid  polymerase and gets incorporated into both 
  
viral and host deoxyribo nueclic acid. It is equally effective as 
idoxyuridine in treating epithelial disease18 and being highly soluble is 
available only as ointment. Its is given in the dosage of  vidarabine  3% 
ointment 5 times daily  for 10-14 days.  Although it is much less toxic 
punctate keratopathy (similar to idoxyuridine toxicity) can be problem 
with topical use. Its use is generally restricted to viral strains resistant to 
other antiviral agents.  
 
 Trifluridine (Triflurothymidine) is a halogenated pyrimidine 
inhibiting thymidylate synthetase incorporated into viral deoxyribo 
nueclic acid impairing transcription and translation. It is more potent 
than idoxyuridine and Vidarabine in healing dendritic ulcers. Also 
trifluridine is superior to idoxyuridine in the management of steroid-
treated corneal ulcers. Although therapeutic levels of the drug can be 
achieved in the anterior chamber its role is indetermined. It is given in 
the dosage of Trifluridine 1% drops 9times daily for 10-14 days.  
Adverse effects include superficial punctal stenosis, corneal filaments, 
and contact dermatitis. Viral resistance to trifluridine is rare.  
 
  
 Acyclovir (ACV) is a purine analogue. It is specifically activated 
by virus induced thymidine kinase which initiates phoshorylation. 
Subsequently two additional phosphates are added by host-cell kinases 
to produce an active triphosphate form which is inhibitory to viral 
deoxyribo nueclic acid polymerase than host-cell polymerase. Thus 
acyclovir is specific to viral-infected cells with low toxicity. After topical 
application it achieves therapeutic concentration in the anterior 
chamber27. acyclovir  is as equally effective as trifluridine and 
Vidarabine in treatment of herpes simplex keratitis. acyclovir  is less 
toxic to ocular surface than earlier generation antiviral agents and as 
such represents a major therapeutic advance. However, mutant virus 
strains with deficient thymidine kinase continue to replicate; therefore 
the development of drug-resistant strain may poste a problem. It is 
given in the dosage of Acyclovir 3% ointment 5times daily 10-14 days. 
Acyclovir 400mg pill TID for 7-10 days    
 
Famcyclovir is an oral Pencyclovir. It is similar to acyclovir in 
structure and mechanism of action acting against herpes simplex virus 
1, herpes simplex virus  2, herpes zoster virus, ebestine bar virus . It 
  
surpasses acyclovir  in gastro intestinal absorption [77% vs 30%]. It is 
metabolized to Pencyclovir intracellularly [active 20 times as long as 
acyclovir]. Given in dosage of 250 mg oraly bd for 7-10 days in acute 
infectious epithelial herpes simplex virus. 125 mg bd for 1 yr to prevent 
recurrences. It is well tolerated and resolves diseases quickly and 
effectively as topical antiviral and oral acyclovir  
 
Valacyclovir is a prodrug of acyclovir. It has increased gastro 
intestinal uptake. It’s intracellular hydrolysis & 5 times increased 
bioavailability.  Valacyclovir 1000 mg oraly 3 times/day for 7–10 days = 
acyclovir  400mg 5 times/day for 7-10days. In immuno compromised 
patients thrombocytopenic purpura & haemolytic uremic syndrome are 
reported. 
 
 
 
 
 
 
  
DRUGS UNDER RESEARCH  
Bromovinyl Deoxyuridine acts by a mechanism similar to 
acyclovir . It appears to be effective in the treatment of epithelial 
herpetic disease. Recently Gancyclovir ophthalmic gel has been shown 
to be equally effective as acyclovir ointment with the added advantage 
of increased local tolerance. It acts by competitive inhibition of viral 
deoxyribo nueclic acid. 
  
It is likely that antiviral therapy will advance rapidly in the next 
few years with 3-hydroxy –2-phosphonly methoxypropyl cytosine, a 
nucleotide analogue (Cidofovir) showing promise as a broad – spectrum 
antiviral agent. 
 
 
CORTICOSTEROIDS   
Use of steroid is recommended in certain types of herpes simplex 
virus infection of the cornea. Corticosteroids suppress inflammation by 
interfering with the normal immunological response to various stimuli 
and are an important management tool37. 
 
  
 
 The advantages of use of steroids in ocular herpes are  
Significant inhibition of  
(1) Cellular infiltration  
(2) Release of toxic hydrolytic enzymes 
(3) Scar tissue formation  
(4) Neovascularization.     
On the negative side, steroids  
1) Suppress the normal inflammatory responses, which may 
allow deeper spread of a potentially superficial viral 
infection  
2) Open the cornea to opportunistic bacterial or fungal 
infection through suppression of the immune defence 
system  
3) Enhance collagenolytic enzyme production by most 
steroids. 
4) Steroid induced glaucoma and cataract. 
 
 
  
 
Their use is restricted to the management of stromal keratitis and 
herpetic uveitis. Steroids do not appear to increase the risk of acquiring 
herpes simplex virus infection but certainly promote severity of the 
disease when present. Infectious crystalline keratopathy is a recognized 
complication of steroids treatment for herpes simplex keratitis. The 
major problem with steroids is inappropriate use at the epithelial stage 
particularly as it may improve the symptoms initially. Over-the-counter 
treatment is undoubtedly responsible for converting what may have 
been relatively benign disease into irreversible corneal damage. 
  
The strategy for topical corticosteroid therapy of stromal keratitis 
should be frequent initial administration (every 1-4 hours) followed by 
tapering of the dose based on the clinical response. Frequently, there 
will be a threshold below which the stromal inflammation will flare. 
Therefore, patients should be tapered to the lowest possible steroid 
dosage that controls their inflammation. 
 
 
 
  
HERPETIC EYE DISEASE STUDY 
 Herpes simplex virus stromal keratitis controlled trial of oral 
acyclovir  
• Oral acyclovir  has no beneficial effect on the time of treatment, 
resolution of keratitis, speed of resolution or 6 months best 
corrected visual acuity in stromal keratitis 
 Herpes simplex virus  stromal keratitis controlled trial of topical 
corticosteroids 
• Topical corticosteroids reduces the persistence and progression 
and shortens the duration of stromal keratitis 
 Herpes simplex virus epithelial keratitis controlled trial of oral 
acyclovir  
• Oral acyclovir  has no benefit in preventing stromal keratitis 
and iritis 
 Herpes simplex virus iridocyclitis controlled trial of oral acyclovir  
• Oral acyclovir  has a beneficial effect in treatment of Herpes 
simplex virus  iridocyclitis  
 Long term acyclovir  in recurrence of epithelial and stromal 
keratitis   
  
• Not a great difference in recurrence of blepharitis, epithelial 
keratitis or iritis was seen on long term acyclovir  prophylaxis. 
However, a significant reduction in recurrence of stromal 
keratitis is noted with long term acyclovir  
 
 
 
 
 
 
 
 
 
 
 
 
  
MEDICAL TREATMENT: 
PRIMARY OCULAR AND PERIOCULAR HERPES SIMPLEX VIRUS 
INFECTIONS.  
In the immunologically competent host, herpetic skin lesions 
remain fairly localized and are a self limited disease that resolves 
without scarring and often without specific therapy.  
1.  In the absence of corneal ulceration, prophylactic topical antiviral 
therapy with trifluridine or vidarabine or acyclovir to the eyes until the 
skin lesions resolve.  
2.  In the presence of corneal ulceration, simple debridement of the 
ulcer followed by antiviral ointment or drops for 14 to 21 days.   
3.  Eye shields in young children.  
4.  Topical povidone iodine to badly ulcerated skin,  
5.  Topical antibiotics if the cornea is ulcerated.  
6.  Cycloplegic if iritis is present. 
7.  Oral antiviral therapy with acyclovir, valacyclovir, or famciclovir 
for 1 week is used to limit corneal epithelial involvement and, 
although unproven, possibly reduce the risk of recurrences.  
 
  
RECURRENT HERPES SIMPLEX VIRUS  OCULAR DISEASE    
HERPES SIMPLEX VIRUS  BLEPHARITIS 
1. Protect the globe.  
2. Prophylactic antiviral ointment 3 times per day or drops 5 to 6 
times per day until the lesion scabbed.    
HERPES SIMPLEX VIRUS  CONJUCTIVITIS  
1. Topical trifluridine 9 times a day or Acyclovir 3% ointment 5    
      times a day for 2 weeks. 
 RECURRENT INFECTIOUS EPITHELIAL HERPES:  
1. Gentle debridement of involved epithelium.  
2. Acyclovir 3% ointment 5 times a day, or Trifluridine 1% 9times 
per day or Vidarabine 3% ointment 5 times per day for 14-21 
days.   Then the therapy is discontinued or rapidly tapered 
even if healing is not complete. It indicates viral resistance or 
trophic sterile ulceration.  
3.   Oral acyclovir  400 mg 3 times per day or famciclovir 500 mg 2 
times   per day or Valacyclovir 0.5 to 1 gm twice a day for 10 
days. 
4.   Topical antibiotics BD while ulcers are present.  
  
5.   Cycloplegic if iritis present.  
6.  No place for the use of steroids in infectious epithelial disease 
uncomplicated by major stromal immune reaction.  
 
TROPHIC POSTINFECTIOUS ULCERS:  
Aimed at protecting the damaged basement membrane. There is 
no call for topical steroids or for antiviral therapy.  
1.  High water content therapeutic contact lens worn around the 
clock for 12 to 24 weeks.  
2.  Un preserved artificial tears four to five times a day while lens is 
worn and then for 4 to 6 months after removal of contact lens.  
3.  In some cases with major stromal edema use of mild steroids 
(0.125% prednisolone 1 to 4 times per day) with antiviral ointment 
as prophylaxis against recurrence.  
4.  Doxycycline or tetracycline to inhibit collagenase 
5.  Cycloplegic are necessary if iritis is present and also to increase 
soft contact lens tolerance.  
6.  Cyanoacrylate glue in ulcer bed to stop melting.  
7.  Patch graft or conjuctival flap, PKP if all else fails.   
  
VIRAL NECROTIZING KERATITIS, INTERSTITAL KERATITIS, 
IMMUNE RINGS AND LIMBAL VASCULITIS:  
 Steroids still remain the prime therapeutic mode for stromal 
disease, with antiviral drugs used primarily as prophylaxis against 
recurrent infectious disease37. Therapeutically a general guideline is that 
if steroids have never been used in a particular eye, the physician 
should try not to use them.   
 
1.  In mild or off-visual axis cases artificial tears are sufficient.  
2.  Cycloplegic as needed for iridocyclitis.  
3.  Topical steroids are used if iridocyclitis progresses, visual axis is 
threatened or transplant surgery is anticipated or if steroids have 
been used previously. 0.1% dexamethasone or 1% prednisolone 
every 4 hours for severe disease to 0.125% prednisolone acetate 
every day to every other day for milder disease.  
4.  Topical antiviral and topical antibiotics as prophylaxis if steroids 
are used. 
  
5.  If the epithelium is ulcerated, reduce or stop topical steroids and 
start on systemic prednisolone (20-30mg orally twice daily for 7-
10 days) and then taper.  
6.  Systemic acyclovir 400 mg BD for 1year or longer is shown to 
reduce the rate of recurrences.  
7.  If the eye remains uninflamed with little or no steroid treatment 
for six months, then keratoplasty can be done.  
 
STROMAL DISCIFORM DISEASE:  
It is highly steroid sensitive. Guidelines for treatment of disciform 
diseases are similar to those of antigen antibody complex-mediated 
disease. Artificial tears and dark glasses may also increase patient 
comfort until the reaction is resolved.  
 
COMBINED EPITHELIAL AND STROMAL DISEASE  
Active viral infection- start antiviral 1-2 days before steroid  
If steroid already in use – then decreases dosage or stop topical 
steroids and start on systemic steroids and topical antiviral until 
epithelium start to heal.  
  
If tropic ulcer with immune keratitis mild topical steroids and 
therapeutic contact lens  
 
IRIDOCYCLITIS AND TRABECULITIS:  
1.  Cycloplegic 
2.  Topical steroids therapy may range from every 3 hours for severe 
involvement to once per day for mild disease, then gradually 
tapered and stop.  
3.  If the cornea has ulcerated or is melting systemic prednisolone 7 
to 14 days and tapered. 
4.  Antiviral drops and topical antibiotics as prophylaxis  
5.  Carbonic anhydrase inhibitors, beta blockers, or both should be 
given if secondary glaucoma is present.  
6.  Oral acyclovir  can be considered in severe cases. 
 
 
 
 
 
 
  
INDICATIONS FOR SYSTEMIC ACYCLOVIR IN HERPETIC 
KERATITIS28:  
Primary herpes simplex virus  infection  
Immuno compromised patient  
Recurrent herpes simplex virus  keratitis in children  
As prophylaxis, post keratoplasty in patients with known history of 
herpes simplex keratitis  
In severe cases of iridocyclitis / endothelitis  
In stromal keratitis to prevent recurrence   
 
 
 
 
 
 
 
 
 
 
  
SURGICAL MANAGEMENT 
 Surgical procedures may sometimes be necessary to treat acute 
and or chronic complications of herpes simplex keratitis .  
 
PENETRATING KERATOPLASTY:  
Penetrating keratoplasty is done not just to restore vision in a 
relatively quiet eye but in an eye with significant ulceration or 
perforation, or to remove the viral antigenic material lodged in the 
cornea and inciting repeated immune inflammatory episodes8.  
 Factors leading to success rate greater than 80 percent  
1.  Operation on an eye uninflamed for 6 months. 
2.  No deep neovascularization or, if present, neovascularization 
involving less than one quadrant.  
3.  Intensive topical corticosteroid therapy may reduce 
vascularization prior to penetrating keratoplasty.  
4.  Use of fine (No.10-0 nylon) sutures.  
5.  Use of high doses of topical steroids in the immediate 
postoperative period and tapered use of steroids over the ensuing 
3 or 4 months.  
  
 Controversy persists regarding the use of prophylactic antiviral 
therapy following penetrating keratoplasty. In reported clinical series of 
penetrating keratoplasty for herpetic keratitis the frequency of recurrent 
epithelial keratitis has ranged from 6% to 75% of cases3, and the majority 
of these recurrences occurred within the first year following surgery. 
Antiviral therapy appeared to decrease the percentage of epithelial 
recurrences. Because allograft rejection accompanied epithelial 
recurrences in 25% of cases, antiviral therapy also appears to be 
associated with improved graft survival. Oral acyclovir may be 
preferable to chronic topical antiviral in patients with recent penetrating 
keratoplasty to prevent epithelial toxicity.  
 
Other treatment modalities include use of cyanoacrylate glue in 
small perforations as a temporary measure. Conjuctival flap, 
tarsorraphy and botilinum induced ptosis may have a role in selected 
cases of nonhealing ulcers, particularly where donor tissue and expert 
postoperative management is not available.  
 
 
  
IMMUNO COMPRAMISED PATIENTS 
 1) Topical antiviral ointment or drops in full therapeutic dosage 
 2) Systemic oral acyclovir 400mg 4 times/day for 2-3 wks or IV 5 
mg/kg body wt for 3-5 days and then the patient is switched over to 
oral acyclovir 400 mg BD 5 times a day for 2-3 wks and then tapered to a 
long term maintenance therapy for 400mg orally twice daily to prevent 
recurrence. 
  
3) Acyclovir resistant herpes simplex virus strains are increasingly 
isolated from HIV patients and do not produce thymidine kinase for 
drug activation. Alternative drug vidarabine which is activated by 
cellular and viral thymidine kinase and foscarnet which needs no 
phosphorylation can be used.  
  
4) Topical α - 2A interferon treatment of herpes simplex virus 
resistant to multiple antiviral drugs has also been reported as effective 
 
 
 
 
 
  
REFRACTIVE SURGERY 
Herpes simplex virus  recurrences are reported from day one after 
LASIK. This is due to reactivation of latent virus. Many prefer not to do 
refractive surgery in patients with a history of herpes. A good history 
prior to refractive surgery is a must. Eye should be quiet for at least 2 
yrs with no herpes simplex virus infection. Prophylactic acyclovir 400 
mg oraly BD 3times/day starting 1-2 wks prior & continue for several 
weeks to months after refractive surgery.  
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AIM OF THE STUDY 
 
 
The main objective of the study is 
 To study the clinical pattern 
 To assess the disease free intervals 
 To assess the visual outcome 
Of recurrent herpes simplex keratitis in Government Rajaji 
Hospital – Madurai.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
MATERIALS AND METHODS 
 
 
46 patients were examined over a period of 1 year at the cornea 
services Government Rajaji Hospital – Madurai 
 
All patients with a clinically documented recurrent herpes 
simplex infection who were treated in our hospital were included in the 
study. 
 
They were analysed retrospectively using a standardized 
questionnaire which assessed the age, sex, clinical type of previous 
herpes simplex virus corneal disease, duration of disease free interval, 
trigger factors if any, laterality of the disease.  
 
A detailed slit lamp examination was done and the clinical type of 
herpes simplex keratitis was assessed. 
 
 
  
A diagnosis of epithelial keratitis was made when a branching 
linear dendritic ulcer or a geographic ulcer appearing as a broad area of 
epithelial defect with amoeboid borders was seen. 
 
Stromal keratitis was diagnosed when deeper layers of corneal 
stroma showed diffuse infiltration and odema of the stroma with or 
without necrosis, ulceration and vascularization. Necrotizing keratitis, 
interstitial keratitis, immune ring, limbal vasculitis, disciform keratitis 
are included in this. 
 
Keratouveitis was diagnosed when there was a severe corneal 
odema with or without vascularization and marked signs of anterior 
uveitis. Since it was difficult to differentiate clinically mild keratouveitis 
and endothelitis, both were clubbed together for the pattern of analysis 
of recurrences. 
 
Neurotropic ulcer was diagnosed when the patients presented 
with persistent epithelial defect with grey thickened elevated borders.  
  
The uniform treatment policy was adopted. Epithelial keratitis 
was treated with topical 3%acyclovir ointment 5 times a day for 2-3 
weeks and topical ciprofloxin eye drops BD.  
 
Stromal keratitis was treated with topical prednisolone acetate in 
dosage according to the disease severity along with prophylactic 3% 
Acyclovir ointment BD and prophylactic ciprofloxin drops BD  along 
with homatropine eye drops BD. 
 
Iridocyclitis was treated in the same way as stromal keratitis. 
Secondary glaucoma was treated with 0.5% timolol eye drops BD. 
 
When the patient has a combined  pattern of epithelial & Stromal 
keratitis he was initially  treated with topical 3% acyclovir ointment, 
homatropine eye drops BD  and ciprofloxin  eye drops BD until the 
epithelium starts healing and then was  started on prenisolole  acetate  
drops. 
 
  
 These patients were followed up for one year using slit lamp 
examinations at 3 specified follow up visits during the one year and at 
additional times when the patient developed new ocular complaints. 
 
 Of the 46 patients 12 patients lost follow up and were excluded 
from the study. 
 
The pattern of recurrence was studied for epithelial and stromal 
keratitis. 
 
The average disease free interval was calculated for epithelial and 
stromal keratitis taking into account only those eyes which recurred 
purely in the same pattern as its initial presentation.    
 
 
 
 
 
 
 
 
 
 
  
RESULTS AND OBSERVATION  
 
AGE DISTRIBUTION 
Table - 1 
Age No.of 
patients 
Percentage 
0-10 0 0 
11-20 3 8.82 
21-30 3 8.82 
31-40 10 29.41 
41-50 11 32.36 
51-60 3 8.82 
61-70 4 11.77 
>71 0 0 
Total 34  
 
            Of the total of 34 patients the average age was found to be 40.38 
yrs with the range between (12 – 69). 21 patients (61.77%) of the patients 
were in the age group of 31 – 50 yrs.  
 
SEX DISTRIBUTION 
Table -2 
Gender No. of  patients Percentage 
Male 18 52.94 
Female 16 47.06 
 
Men and women were found to have almost equal incidence of 
the disease with men accounting for 52.94% (18 patients) and women 
47.06% (16 patients).  
  
 
LATERALITY OF THE DISEASE 
 
Table - 3 
Laterality No. of  patients Percentage 
Unilateral 31 91.17 
Bilateral 3 8.83 
 
Bilateral disease was seen in 3 patients accounting for 8.83 % of 
the patients. Of the 3 patients one patient showed simultaneous 
involvement. Clinical manifestations were similar in all those with 
bilateral disease pattern.  
 
 
 
 
 
 
 
 
 
  
PATTERN OF INITIAL PRESENTATION 
Table - 4 
Pattern of initial Presentation No. of Eyes Percentage 
Epithelial 20 54.05 
Stromal 11 29.72 
Epithelial + Stromal 3 8.10 
Uveitis 3 8.10 
 
Epithelial keratitis was found in 54.05% (20 eyes) of the 34 eyes 
and stromal keratitis was found in 29.72% (11 eyes). 8.10% of eyes (3 
eyes)  showed a combined pattern of epithelial and stromal keratitis and 
8.10% (3 eyes) showed features of uveitis.  
PATTERN OF INITIAL PRESENTATION  
Table - 5 
Pattern  No. of Eyes  Percentage  
Epithelial (N = 20) 
       Dendritic 
       Geographic  
       SPK  
 
12 
4 
4 
 
38.24 
11.76 
11.76 
Stromal (N = 11) 
       Disciform  
      Interstitial keratitis   
 
7 
4 
 
18.91 
10.81 
Epithelial + Stromal    3 8.82 
Uveitis  3 8.82 
 It was found that of the 20 cases with epithelial keratitis 12 
(38.24%) were found have a dendritic pattern 4 (11.76%) with 
Geographic pattern and 4 (11.76%) had Superficial punctate keratitis. Of 
the 11 patients with stromal keratitis 7 (18.91%) were found have 
disciform pattern while 4 (11.76%) had Interstitial keratitis. 
  
PATTERN OF RECURRENCE IN EPITHELIAL KERATITIS 
 
Table - 6 
Pattern of recurrence 
Epithelial 
No. of Eyes Percentage 
Epithelial 13 65% 
Stromal 6 30% 
Metaherpetic 1 5% 
 
Of those with epithelial disease (20 eyes) the pattern of recurrence 
was in the form of epithelial disease every time in 13 eyes (65%) and 6 
eyes (30%) demonstrated stromal disease. One patient (5%) showed a 
metaherpetic pattern on recurrence.  
PATTERN OF RECURRENCE IN STROMAL KERATITIS 
Table - 7 
Pattern of recurrence No. of Eyes Percentage 
Epithelial 1 9% 
Stromal 9 82% 
Epithelial + Stromal 1 9% 
 
 Of the 11 eyes which presented initially with stromal keratitis it 
was found that 9 eyes recurred only as stromal keratitis which 
accounting for 81.81% of eyes. One (9%) eye recurred as epithelial 
keratitis while one (9%) more eye had a combined pattern of epithelial 
and stromal keratitis. 
 
  
PATTERN OF RECURRENCE FOLLOWING INITIAL UVEITIS  
 
Table - 8 
Pattern of recurrence No. of Eyes Percentage 
Epithelial 1 33.33% 
Stromal 0 0% 
Uveitis  2 66.66% 
 
 Of the 3 patients with Uveitis 2 (66.66%) to of them recurred in the 
same pattern while 1 patient (33.33%) recurred as epithelial keratitis.    
 
PATTERN OF RECURRENCE FOLLOWING INITIAL 
EPITHELIAL + STROMAL KERATITIS 
 
Table - 9 
Pattern of recurrence  No. of Eyes Percentage 
Epithelial Nil - 
Stromal  1 33.33% 
Epithelial + Stromal 2 66.66% 
 
 
 
Of the 3 patients with epithelial and stromal keratitis 2 (66.6%) of 
them recurred in the same pattern while 1 patient (33.3%) recurred with 
stromal keratitis only. 
 
 
  
NUMBER OF RECURRENCES 
 
Table - 10 
Number of recurrence  No. of Eyes Percentage 
1 or 2 23 62.16 
>2 14 37.83 
 
 
Eyes recruited in this study demonstrated 1-4 recurrences. 23 eyes 
(62.16%) showed only 1 or 2 recurrences while 14 eyes (37.83%) showed 
more than 2 recurrences.  
PATTERN OF RECURRENCE AND NUMBER OF 
RECURRENCE 
 
Table - 11 
Pattern Total 
 
No of eyes 
with > 2 
recurrence 
Percentage 
Epithelial 20 3 15 
Stromal 11 5 45.45 
Epithelial+ Stromal 3 3 100 
Uveitis  3 3  100 
 
Also only 3 of the 20 eyes (15%) with epithelial keratitis showed 
more than 2 recurrences while 5 of the 11 eyes (45.45%) with stromal 
keratitis showed more than 2 recurrence and all the 3 cases with 
epithelial and stromal keratitis showed more than 2 recurrences and all 
three cases with Uveitis showed more than 2 recurrences.  
  
DISEASE FREE INTERVAL 
 
Table -12 
 
Pattern of recurrence Disease free interval (months) 
Epithelial 21.52 
Stromal 7.09 
Epithelial+ Stromal 6.75 
Uveitis  8.55 
 
 
Patients with recurring stromal keratitis were found to have an 
average disease free period of 7.09 months between attacks. Those with 
epithelial + stromal keratitis were also found to have a shorter time 
interval of about 6.75 months between the attacks and those with Uveitis 
were found have an average disease free period of 8.55 months. 
Epithelial recurrences were found to have a longer disease free interval 
of an average of 25.52 months in between episodes.  
 
 
  
 
DISEASE FREE INTERVAL IN BETWEEN RECURRENCE 
 
Table - 13 
Disease free interval (months)  
I II III IV 
Epithelial 22 19 10 - 
Stromal 8.86 6.16 5.75 4.5 
Epithelial+ Stromal 10.5 8.5 4.5 3.5 
Uveitis  14 10 4.5 3 
 
 
It was found that the disease free interval in between subsequent 
attacks decreased in all cases. In case of epithelial keratitis the average 
disease free interval in first recurrence was found to be 22 months and 
second recurrence 19months and third recurrence 10months. In stromal 
keratitis the average disease free interval for 1st , 2nd , 3rd and 4th 
recurrences  was found to be 8.86 months , 6.16months, 5.75months and 
4.75 months respectively while for cases with epithelial + stromal 
keratitis it was 10.5 months, 8.5months, 4.5months and 3.5months 
respectively and in Uveitis it was 14 months, 10months, 4.5 months and 
3 months respectively .  
 
 
  
VISUAL OUTCOME FOLLOWING TREATRMENT. 
Table - 14 
Patients who lost 2 or more lines of 
vision 
No.of 
recurrence 
Total  
No. Percentage 
1 or 2 23 2 8.69% 
>2 14 9 64.28% 
 
Table - 15 
Patients who lost 2 or more 
lines of vision 
Patterns of 
recurrence 
Total 
No. Percentage 
Epithelial  20 3 15% 
Stromal 11 4 36.36% 
Epithelial + 
Stromal  
3 2 66.6% 
Uveitis  3 2 66.6% 
 
 
It is being observed from the study that while only 2 of the 23 
patients with less than 2 recurrence showed a decrease in vision by 2 
lines 9 of the 14 patients with >2 recurrence (64.28%) showed a decrease 
in vision by 2 or more lines 
Also it was seen that while only 15% of patients with epithelial 
keratitis showed a decrease in vision by 2 lines or more 36.36% of 
patients with stromal keratitis and 66.66% of patients with epithelial + 
stromal Keratitis and uveitis showed a loss of vision by 2lines or more.         
  
TRIGGER FACTORS 
Table - 16 
Trigger factor No. of Eyes Percentage 
Fever 5 14.7% 
Ocular trauma  3 8.83% 
Psychological Stress 1 2.94% 
URI 3 8.83 
Spontaneous 22 64.70% 
 
A trigger for recurrence was identified only in 10 patients 
(29.42%). The major precipitating factors for recurrences were a history 
of Fever in 5 patients (14.17%); ocular trauma in 3 patients (8.84%); 
psychological stress in 1 patient (5.88%) and Upper respiratory tract 
infection in 3 patients (8.83%). Majority – 21 of the patients (70.58%) 
showed only a spontaneous onset of recurrence.  
COMPLICATIONS 
Table - 17 
Complication No. of Patients 
Metaherpetic ulcer  1 
Glaucoma  1 
Corneal scarring  3 
 
  During the study it was observed that 1 patient with epithelial 
keratitis while on treatment developed a metaherpetic pattern. One 
patient with Uveitis developed secondary glaucoma. 3 patients with 
stromal keratitis developed residual stromal scarring, while almost all 
cases of epithelial keratitis healed without much residual effect.       
  
DISCUSSION 
The average age was found to be 40.38 yrs with the range between 
(12 – 69). 21 patients (61.77%) fall in the age group of 31 – 50 yrs. This is 
comparable with the study of Saini and Agarwal et al which shows 
67.5% of patients in the age group of 31 – 60 yrs and also with 
Wilhelmus KR, Coster DJ, Donovan HC, Jones BR, Falcon MG et al 
which shows a higher incidence of herpetic keratitis at 40 – 60 yrs. 
 
Men and women were found to have almost equal incidence of 
the disease with men accounting for 52.94% (18 patients) and women 
47.06% (16 patients).  
 
3 patients showed bilateral involvement accounting for 8.83 % of 
the patients and only one of them showed simultaneous involvement. 
Clinical manifestations were similar in both eyes. This agrees with the 
findings of Uchio. E, Hantano H, Mitsui K, Sugita M, Okada K, Goto K , 
Kagiya M , Enomoto Y, Ohno S et al  and Liesegang TJ et al who 
reported 10.4% and 11.9% of bilateral disease respectively. 
  
In their initial presentation 54.05% (20 eyes) of the eyes showed 
epithelial pattern and stromal keratitis was found in 29.72% (11 eyes). 
8.10% of eyes (3 eyes) had a combined pattern of epithelial and stromal 
keratitis and 8.10% (3 eyes) showed features uveitis. This is consistent 
with of Uchio.E, Hantano H, Mitsui K, Sugita M, Okada K, Goto K , 
Kagiya M , Enomoto Y, Ohno S et al  who in their study found 57.3% of 
epithelial keratitis and 39.3% of stromal keratitis but in contrast with 
Saini and Agarwal et al who showed 62.5% of stromal keratitis and 
27.5% of epithelial keratitis. 
 
Among the 20 cases with epithelial keratitis 12 (38.24%) were 
found have a dendritic pattern, 4 (11.76%) with Geographic pattern and 
4 (11.76%) had Superficial punctate keratitis. Of the 11 patients with 
stromal keratitis 7 (18.91%) were found have disciform pattern while 4 
(11.76%) had interstitial keratitis. On reviewing the literature “A study 
of Virology & clinical features of herpes simplex keratitis in south India” 
has showed 43.33% of dendritic ulcer 11.33% of geographic ulcer 11.33% 
of SPK, 16.66% of Disciform keratitis and 6.66% immune ring.            
 
  
Of those with epithelial disease (20 eyes) the pattern of recurrence 
was in the form of epithelial disease every time in 13 eyes (65%) and 6 
eyes (30%) demonstrated stromal disease. One patient (5%) showed a 
metaherpetic pattern on recurrence. This is in agreement with Saini and 
Agarwal et al and with Wilhelmus KR, Coster DJ, Donovan HC, Jones 
BR, Falcon MG et al who state that previous dendritic and geographic 
ulcers lead to subsequent dendrites and geographic ulcers. 
 
 Similarly among the 11 eyes which presented initially with 
stromal keratitis it was found that when 9( 81.81%) of eyes  recurred 
only as stromal keratitis only one (9%) eye recurred as epithelial 
keratitis while another one (9%) eye had a combined pattern of 
epithelial and stromal keratitis. This goes in hand with the study of Saini 
and Agarwal et al which showed 84% of stromal keratitis recurring only 
as stromal keratitis. Wilhelmus KR, Dawson CR, Barron BA, Bacchetti P, 
Gee L, Jones DB et al (for Herpetic eye disease study group) also shows 
low recurrences of epithelial disease in eyes manifesting herpes simplex 
virus  stromal disease. 
 
  
 Of the 3 patients with Uveitis, 2 (66.66%) of them recurred in the 
same pattern while 1 patient (33.33%) recurred as epithelial keratitis.    
 
Of the 3 patients with epithelial and stromal keratitis, 2 (66.6%) of 
them recurred in the same pattern while 1 patient (33.3%) recurred with 
stromal keratitis only. Thus it is seen that Herpes simplex keratitis often 
recurs in the same clinical pattern as the first episode, which could be 
due to the concept that viral strains determine the clinical pattern of the 
disease.  
 
Eyes recruited in this study demonstrated 1-4 recurrences. 23 eyes 
(62.16%) showed only 1 or 2 recurrences while 14 eyes (37.83%) showed 
more than 2 recurrences. This is almost consistent with Wishart MS, 
Darougar S, Viswalingam ND et al studies which showed 40% of 
patients showing 3-5 attacks and with Saini and Agarwal et al showing 
27.5% of patients showing more than 2 recurrences. 
 
It was also observed when only 15% of the eyes with epithelial 
keratitis showed more than 2 recurrences 45.45% with stromal keratitis 
  
showed more than 2 recurrence and all the 3 cases with epithelial and 
stromal keratitis showed more than 2 recurrences and all three cases 
with Uveitis showed more than 2 recurrences. This is in agreement with 
Zhonghu Yan Ke Za Zhi et al who state that the recurrence rate was 
significantly higher in cases with stromal involvement or iritis. This 
could be because more virulent strains are involved in stromal keratitis 
and that this therapeutic regimen had little effect on viral particle 
related stromal keratitis. 
 
It was also observed that while patients with recurring stromal 
keratitis have an average disease free period of 7.09 months between 
attacks and those with epithelial + stromal keratitis had 6.75 months 
between the attacks and those with Uveitis were found have an average 
disease free period of 8.55 months. But epithelial recurrences were 
found to have a longer disease free interval of an average of 25.52 
months in between episodes. This is consistent with the finding of Saini 
and Agarwal et al who found almost a 4 times longer average disease 
free interval in epithelial keratitis when compared to stromal keratitis 
.This also goes in hand with Shuster JJ, Kaufman HE, Nesburn AB, et al 
  
who stated that the time difference in disease free interval between 
epithelial and stromal keratitis is statistically significant (p<0.005). 
 
It was found that the disease free interval in between subsequent 
attacks decreased in all cases.  
           
A trigger for recurrence was identified only in 10 patients 
(29.42%). The major precipitating factors for recurrences were a history 
of fever in 5 patients (14.17%); ocular trauma in 3 patients (8.84%); 
psychological stress in 1 patient (5.88%) and Upper respiratory tract 
infection in 3 patients (8.83%). This suggests that some form of physical 
or emotional stress acts as a trigger. Majority – 21 of the patients 
(70.58%) showed only a spontaneous onset of recurrence. On reviewing 
the literature “A study of virology and clinical features of Herpes 
simplex keratitis in South India” showed 51.51% with spontaneous 
onset, 24.24% had fever while 6.06% had ocular trauma and 13.63% had 
exposures to sunlight and 4.54% had URI.    
 
  
 During the study 1 patient with epithelial keratitis while on 
treatment developed a metaherpetic pattern. Metaherpetic ulcer was 
treated with intermittent 48 hr pressure patching with ciprofloxin eye 
ointment artificial tears qid and continued for 2-3 months after removal 
of patch. Homatropine eye drops BD was added. One patient with 
Uveitis developed secondary glaucoma and was treated with 
0.5%timolol eye dps BD. 3 patients with stromal keratitis developed 
residual stromal scarring, while almost all cases of epithelial keratitis 
healed without much residual effect. 2 of the patients with corneal 
scaring had deep vascularisation and PKP was deferred and another 
patient is kept on follow up to take up for PKP after his eyes remain 
quiet for 6 months.    
 
          Only 2 of the 23 patients with less than 2 recurrence showed a 
decrease in vision by 2 lines, 9 of the 14 patients with >2 recurrence 
(64.28%) showed a decrease in vision by 2 or more lines. This is because 
with each recurrence there is increased risk of stromal inflammation and 
consequent permanent corneal scarring leading to decrease in visual 
outcome. 
  
 Also it was seen that while only 15% of patients with epithelial 
keratitis showed a decrease in vision by 2 lines or more, 36.36% of 
patients with stromal keratitis and 66.66% of patients with epithelial + 
stromal Keratitis and uveitis showed a loss of vision by 2lines or more.  
This could again be because of the increased inflammation and scarring 
associated with these patterns of disease.       
 
 
 
 
 
 
 
 
 
 
 
  
CONCLUSION 
Herpes simplex eye infection is an important cause of corneal 
blindness. Recurrences of the disease are the major cause of ocular 
morbidity. 
 
It is being seen from the study that herpes simplex disease often 
recurs in the same clinical pattern as the first episode. It is also seen that 
stromal involvement though accounting for only about 30% of the initial 
presentation, it is the one which shows more number of recurrence at a 
shorter interval of time than that of epithelial involvement. Thus stromal 
keratitis accounts for the major cause of ocular morbidity due to herpes 
simplex keratitis. Hence an early recognition and prompt treatment is 
necessary and more light is to be shown on the ways of preventing 
recurrences through subsequent studies.      
 
 
 
 
 
  
CLINICAL PATTERN OF RECURRENCE HERPES 
SIMPLEX KERATITIS 
PROFORMA 
1) Name   : 
2) Ip/Op No   : 
3) Age    : 
4) Sex    : 
5) Detail of previous attack 
Initial attack     
Date   :  
Pattern  : 
Treatment  : 
Trigger factor :   
Disease free interval: 
Recurrences 
1     2  
Date    :  Date    : 
Pattern  :  Pattern  :  
Treatment  :  Treatment  : 
Trigger factor  :  Trigger factor  :  
Disease free interval :  Disease free interval: 
3     4  
Date    :  Date   :  
Pattern  :  Pattern  : 
Treatment  :  Treatment  : 
  
Trigger factor  :  Trigger factor  :  
Disease free interval :  Disease free interval:  
6) Details of follow up  
1) Date      2) Date 
S/L Examination -Lids         S/L Examination - Lids  
Conjuctiva                                     Conjuctiva  
Cornea        Cornea    
AC       AC 
Iris        Iris  
Pupil        Pupil 
Lens        Lens  
Staining      Staining  
Vision       Vision 
 
3) Date        
    S/L Examination – Lids    
    Conjuctiva       
     Cornea         
      AC 
     Iris           
    Pupil         
     Lens          
Staining         
Vision        
 
  
 
7) Number of recurrence 
 
 
8) Laterality of the Disease  
      Unilateral 
       Bilateral  
9) Trigger Factors  
Fever  
Trauma  
Ocular Surgeries  
Non ocular surgeries  
Upper Respiratory tract infection 
Exposure to UV rays (sunlight) 
Menstruation 
Psychological stress 
Steroid Exposure     
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I II III IV I II III IV I II III
1 Sivanandi 34 M E 6/24 6/18 1 E U/L 31 6/18
2 Pappathi 46 F E 6/36 6/18 1 E U/L Fever 22 6/18
3 Samykannu 65 M E 4/60 6/60 1 E U/L 21 6/60
4 Pachi 35 F E 6/36 6/18 1 E U/L 18 6/18
5 Saroja 54 F E 6/60 6/36 1 E U/L Ocular trauma 25 6/36
6 Balan 12 M E 6/9 6/6 1 E U/L 14 6/6
7 Sanbagam 63 F E 4/60 6/60 1 E U/L 22 5/60
8 Muthu 45 M E 6/36 6/18 1 E U/L Stress 27 6/18
9 Kathamuthu 32 M E 6/24 6/6 1 E B/L 33 6/6
10 E 6/18 6/6 1 E 15 6/6
11 Karupi 47 F E 6/36 6/24 1 S U/L 12 6/36
12 Kalai 22 M E 6/18 6/9 1 S U/L URI 14 6/12
13 Podunponnu 42 F E 6/36 6/18 2 E E U/L 24 21 6/24 6/24
14 Muthukalai 69 M E 4/60 6/60 2 E E U/L Metaherpetic 21 19 6/60 5/60
15 Banumathi 35 F E 6/9 6/6 2 E S U/L Fever 22 16 6/6 6/12
16 Kalimuthu 37 M E 6/12 6/6 2 S S U/L 19 6 6/12 6/18
17 Sankar 45 M E 6/36 6/36 2 S S U/L 14 10 6/36 6/60
18 Stalin 27 M E 6/12 6/6 3 E E E U/L 19 17 10 6/6 6/9 6/9
19 Savithi 44 F E 6/36 6/18 4 S S S S U/L Fever 16 15 7 3 6/18 6/18 6/24
20 Krishnan 34 M E 6/18 6/6 4 S S S S U/L Ocular trauma 18 15 8 71 6/6 6/9 6/18
21 Musthapa 48 M S 6/24 6/24 1 S B/L 10 6/24
22 S 6/24 6/18 1 S 7 6/18
23 Santhi 16 F S 6/18 6/6 1 S U/L URI 9 6/6
24 Pandi 63 M S 6/60 6/36 1 E U/L 14 6/36
25 Meena 18 F S 6/9 6/6 2 S S U/L Ocular trauma 11 7 6/9 6/9
26 Murugan 45 M S 6/36 6/24 2 S S B/L 9 4 6/24 6/24
27 S 6/36 6/24 3 S S S Scarring 4 4 3 6/26 6/60 5/60
28 Senthuram 35 F S 6/60 6/36 3 S S S U/L Fever 12 9 17 6/36 6/60 6/60
29 Ganeshan 55 M S 6/60 6/36 4 S S S S U/L 8 6 8 4 6/36 6/36 6/36
30 Visalam 50 F S 6/36 6/24 4 S S S S U/L Scarring 10 7 5 5 6/60 6/60 4/60
31 Rajagopal 28 M S 6/9 6/6 3 E+S E+S E+S U/L 13 8 6 6/6 6/9 6/9
32 Karupayee 43 F E+S 6/24 6/18 3 E+S S S U/L Fever Scarring 9 4 3 6/24 6/36 6/60
33 Thamarai 31 F E+S 6/36 6/18 4 E+S E+S E+S E+S U/L 11 8 5 4 6/18 6/18 6/36
34 Sundarapandi 32 M E+S 6/60 6/24 4 E+S E+S E+S E+S U/L 10 9 4 3 6/24 6/24 6/24
35 Marutayee 53 F U 6/36 6/24 3 U U U Glaucoma 12 9 4 6/24 6/36 5/60
36 Kamala 36 F U 6/60 6/24 4 U U U U U/L URI 16 11 5 3 6/24 6/36 6/36
37 Kaliappan 42 M U 6/60 6/24 3 U U E 10 4 3 6/24 6/24 6/24
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